bf/NASDAQ:CHRS_icon.jpeg

COM:COHERUS

Coherus BioSciences

  • Stock

Last Close

0.82

08/11 21:00

Market Cap

164.06M

Beta: -

Volume Today

3.51M

Avg: -

  • locale

    usUnited States
  • market

    STOCKS
  • industry

    Biotechnology
  • website

    www.coherus.com/
  • ipo date

    Nov 06, 2014

Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripali...Show More

competitor of